S&P Futures
3,857.00 +8.75 (+0.23%) Dow Futures
31,086.00 +73.00 (+0.24%) Nasdaq Futures
11,925.00 +44.75 (+0.38%) Russell 2000 Futures
1,733.70 +5.10 (+0.30%) Crude Oil
98.35 -0.18 (-0.18%) Gold
1,739.20 +2.70 (+0.16%)
Mexco Energy Corporation (MXC)
After hours:
Chart Events
Performance Outlook
| Previous Close | 15.12 |
| Open | 15.36 |
| Bid | 14.46 x 900 |
| Ask | 25.03 x 1000 |
| Day's Range | 14.98 - 16.55 |
| 52 Week Range | 7.80 - 43.00 |
| Volume | |
| Avg. Volume | 57,331 |
| Market Cap | 33.204M |
| Beta (5Y Monthly) | 1.29 |
| PE Ratio (TTM) | 20.35 |
| EPS (TTM) | 0.77 |
| Earnings Date | Feb 08, 2022 - Feb 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
MEXCO ENERGY CORPORATION REPORTS FINANCIAL RESULTS FOR FISCAL 2022
MIDLAND, TX, June 27, 2022 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE American: MXC) reported results on its Annual Report, Form 10-K to the Securities and Exchange Commission for the fiscal year ended March 31, 2022. The Company reported net income of $2,855,066 or $1.36 per diluted share, for fiscal year 2022, compared to net income of $155,932, or $0.08 per diluted share, for fiscal 2021. Operating revenues in fiscal 2022 were $6,587,780, an increase of 135% when compared to fiscal 20
- PR Newswire
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer's in the EU and UK
MGC Pharmaceuticals Ltd. (LSE: MXC, ASX: MXC, OTC:MGCLF), a European based bio-pharma company specializing in the production and development of phytomedicines, has signed an exclusive distribution agreement with Sciensus Rare, a part of UK health care group, Sciensus, for the distribution of CannEpil® and CogniCann® in key European territories and the UK.
- Simply Wall St.
Is MGC Pharmaceuticals (ASX:MXC) Using Debt In A Risky Way?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
